APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $654 | -58.3% | 17,200 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $1,567 | +58.4% | 17,200 | +14.7% | 0.01% | +33.3% |
| Q1 2023 | $989 | +59.3% | 15,000 | +25.0% | 0.01% | +50.0% |
| Q4 2022 | $621 | -99.9% | 12,000 | +2.6% | 0.00% | -20.0% |
| Q3 2022 | $799,000 | +51.0% | 11,700 | 0.0% | 0.01% | +66.7% |
| Q2 2022 | $529,000 | -22.3% | 11,700 | -12.7% | 0.00% | -25.0% |
| Q1 2022 | $681,000 | +7.4% | 13,400 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $634,000 | +43.4% | 13,400 | 0.0% | 0.00% | +50.0% |
| Q3 2021 | $442,000 | -47.8% | 13,400 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $847,000 | +54.3% | 13,400 | +4.7% | 0.00% | +33.3% |
| Q1 2021 | $549,000 | -25.0% | 12,800 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $732,000 | +89.6% | 12,800 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $386,000 | -53.8% | 12,800 | -50.0% | 0.00% | -25.0% |
| Q2 2020 | $836,000 | – | 25,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |